Wang Haiyang, Li Haoran, Jiang Qianqian, Dong Xuchen, Li Suwen, Cheng Shan, Shi Jia, Liu Liang, Qian Zhiyuan, Dong Jun
Department of Neurosurgery, The Second Affiliated Hospital of Soochow University, Suzhou, China.
Front Oncol. 2021 Mar 19;11:603128. doi: 10.3389/fonc.2021.603128. eCollection 2021.
Recent studies have reported that cancer associated fibroblasts (CAFs) and glioma stem-like cells (GSCs) played active roles in glioma progression in tumor microenvironment (TME). Long non-coding RNAs (lncRNAs) have been found to be closely associated with glioma development in recent years, however, their molecular regulatory mechanisms on CAFs in GSCs remodeled TME kept largely unelucidated. Our study found that GSCs could induce malignant transformation of fibroblasts (t-FBs) based on dual-color fluorescence tracing orthotopic model. Associated with poor prognosis, Lnc HOXA transcript antisense RNA, myeloid-specific 1 (HOTAIRM1) was highly expressed in high-grade gliomas and t-FBs. Depleting HOTAIRM1 inhibited the proliferation, invasion, migration, and even tumorigenicity of t-FB. Conversely, overexpression of HOTAIRM1 promoted malignancy phenotype of t-FB. Mechanistically, HOTAIRM1 directly bound with miR-133b-3p, and negatively regulated the latter. MiR-133b-3p partly decreased the promotion effect of HOTAIRM1 on t-FBs. Furthermore, transforming growth factor-β (TGFβ) was verified to be a direct target of miR-133b-3p. HOTAIRM1 can modulate TGFβ competing with miR-133b-3p. Collectively, HOTAIRM1/miR-133b-3p/TGFβ axis was involved in modulating t-FBs malignancy in TME remodeled by GSCs, which had the potential to serve as a target against gliomas.
最近的研究报道,癌症相关成纤维细胞(CAFs)和胶质瘤干细胞样细胞(GSCs)在肿瘤微环境(TME)中的胶质瘤进展中发挥了积极作用。近年来发现长链非编码RNA(lncRNAs)与胶质瘤发展密切相关,然而,它们在GSCs重塑的TME中对CAFs的分子调控机制在很大程度上仍未阐明。我们的研究发现,基于双色荧光追踪原位模型,GSCs可以诱导成纤维细胞(t-FBs)发生恶性转化。与预后不良相关,Lnc HOXA转录本反义RNA,髓系特异性1(HOTAIRM1)在高级别胶质瘤和t-FBs中高表达。敲除HOTAIRM1可抑制t-FB的增殖、侵袭、迁移甚至致瘤性。相反,HOTAIRM1的过表达促进了t-FB的恶性表型。机制上,HOTAIRM1直接与miR-133b-3p结合,并对后者起负调控作用。MiR-133b-3p部分降低了HOTAIRM对t-FBs的促进作用。此外,转化生长因子-β(TGFβ)被证实是miR-133b-3p的直接靶点。HOTAIRM1可以与miR-133b-3p竞争调节TGFβ。总之,HOTAIRM1/miR-133b-3p/TGFβ轴参与调节GSCs重塑的TME中t-FBs的恶性程度,这有可能成为对抗胶质瘤的靶点。